Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Assistant Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology & Hematologic Malignancies
|
| Board Certification |
American Board of Internal Medicine
|
Education history
| Fellowship | Internal Medicine - University of Texas MD Anderson Cancer Center | Fellow |
|---|---|---|
| Internship/Residency | Internal Medicine - University of Alabama at Birmingham Heersink School of Medicine | Intern/Resident |
| Professional Medical | Medicine - Seth G.S. Medical College | M.B.B.S. |
Selected Publications
Journal Article
- Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG (2024). Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms. Haematologica, 110(6), 1304-1315.
- Waldschmidt JM, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, Frede J, Campbell T, Kaiser SM, Zheng X, Munshi NC, Anderson KC, Einsele H, Yee AJ, Knoechel B, Lohr JG, Raje NS (2024). Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma. Blood Adv, 9(5), 1132-1136.
- Fowler ME, Kenzik KM, Al-Obaidi M, Harmon C, Giri S, Arora S, Stephenson C, Khushman M, Outlaw D, Bhatia S, Williams GR (2023). Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: The cancer & aging resilience evaluation (CARE) registry. J Geriatr Oncol, 14(4), 101505.
- Zainaldin C, Arora S, Bathini S, Gupta U, Pandya V, Bae S, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P (2022). Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents. Leuk Lymphoma, 63(13), 3245-3248.
- Arora S, Fowler ME, Harmon C, Al-Obaidi M, Outlaw D, Hollis R, Gbolahan O, Khushman M, Giri S, Williams GR (2022). Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry. JCO Oncol Pract, 18(11), e1796-e1806.
- Arora S, Zainaldin C, Bathini S, Gupta U, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P (2022). Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia. Leuk Res, 117, 106844.
- Gokarn A, Toshniwal A, Pathak A, Arora S, Bonda A, Punatar S, Nayak L, Dwivedi P, Bhat V, Biswas S, Kelkar R, Kannan S, Khattry N (2019). Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant. Biol Blood Marrow Transplant, 25(9), 1832-1836.
Review
- Arora S, Vachhani P, Bose P (2024). Investigational drugs in early phase trials for myelofibrosis. [Review]. Expert Opin Investig Drugs, 33(12), 1231-1244.
- Arora S, Asawa P, Ramakrishnan A, Bachier C, Majhail NS (2022). Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and Challenges. [Review]. Hematol Oncol Stem Cell Ther, 15(3), 159-167.
- Arora S, Asawa P, Kataria N, Hendriks LEL, Desai AP (2022). Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022. [Review]. Cancer Invest, 40(7), 577-589.
Letter
- Jamy O, Arora S, Meredith R, Salzman D, Di Stasi A, Minagawa K, Mineishi S, Saad A (2022). Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy. [Letter to the editor]. Bone Marrow Transplant, 57(10), 1597-1599.
- Tiwari NR, Arora S, Tolat AG, Shaheen SP 2nd, Sharma VR (2021). TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant. [Letter to the editor]. Ann Hematol, 101(3), 725-727.
- Arora S, Vachhani P, Bachiashvili K, Jamy O (2021). Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia. [Letter to the editor]. Leuk Lymphoma, 62(9), 2292-2294.